biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a0cz-01a-11w-a050-09
biospecimen_aliquot__bcr_aliquot_uuid	95d5c606-367a-46b5-b663-dcea3f42e2a2
biospecimen_aliquot__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a0cz-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100470807
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-08-09
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a050
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a0cz-01a-11w
biospecimen_analyte__bcr_analyte_uuid	f691dc9d-8dcd-4cac-984c-32df948ffa74
biospecimen_analyte__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a0cz-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a0cz
biospecimen_diagnostic_slides__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a0cz-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	a433a414-4f1b-4f99-8fd9-e64803f5e042
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a0cz
biospecimen_normal_control__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_normal_control__ncedna_dna_conc	0.209
biospecimen_normal_control__ncedna_dna_qm	spec (nano drop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	95.7
biospecimen_portion__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_portion__bcr_portion_barcode	tcga-a2-a0cz-01a-11
biospecimen_portion__bcr_portion_uuid	71296d81-b1ad-4511-a413-f1c5b4fe8629
biospecimen_portion__bcr_sample_barcode	tcga-a2-a0cz-01a
biospecimen_portion__date_of_creation	2010-06-08
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a0cz-01a-11w
biospecimen_protocol__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a0cz-01a
biospecimen_protocol__experimental_protocol_type	repli-g
biospecimen_sample__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_sample__bcr_sample_barcode	tcga-a2-a0cz-01a
biospecimen_sample__bcr_sample_uuid	aa1e0129-d008-4648-8098-24f1981bc386
biospecimen_sample__days_to_collection	1204
biospecimen_sample__initial_weight	240
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a0cz.57153075-9055-4d7e-9cd6-9167d165e860.pdf
biospecimen_sample__pathology_report_uuid	57153075-9055-4d7e-9cd6-9167d165e860
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a0cz-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	af5345d8-db03-4d37-b327-5a62c1fe1285
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13c
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a0cz-01a-21-a13c-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
biospecimen_slide__bcr_sample_barcode	tcga-a2-a0cz-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a0cz-01a-01-bs1
biospecimen_slide__bcr_slide_uuid	792ef70c-5f29-44df-8d18-0b54697b2cca
biospecimen_slide__image_file_name	tcga-a2-a0cz-01a-01-bs1.792ef70c-5f29-44df-8d18-0b54697b2cca.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	60
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	40
biospecimen_slide__percent_tumor_nuclei	85
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a0cz
biospecimen_tumor_sample__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
clinical_drug__bcr_drug_barcode	tcga-a2-a0cz-d2007
clinical_drug__bcr_drug_uuid	8d024ed9-cab0-4645-9ef7-d2443495432a
clinical_drug__bcr_patient_barcode	tcga-a2-a0cz
clinical_drug__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
clinical_drug__form_completion_date	2010-9-16
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	cytoxan
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ended_days_to	148
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	106
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	1045
clinical_drug__regimen_number	2
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	4180
clinical_follow_up__bcr_followup_barcode	tcga-a2-a0cz-f13728
clinical_follow_up__bcr_followup_uuid	a104937a-eabd-4777-8d6c-1ec71d882f19
clinical_follow_up__bcr_patient_barcode	tcga-a2-a0cz
clinical_follow_up__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-6-10
clinical_follow_up__last_contact_days_to	1616
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	46
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right upper inner quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-a2-a0cz
clinical_patient__bcr_patient_uuid	9f93ea0a-1687-44e0-9e8a-eeb4097d471c
clinical_patient__birth_days_to	-17026
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-9-14
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.1
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2007
clinical_patient__last_contact_days_to	1339
clinical_patient__lymph_nodes_examined_count	2
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	positive
clinical_patient__menopause_status	peri (6-12 months since last menstrual period)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a0cz
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	20-29%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0CZ-01A-11W-A050-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0CZ-01A-11W-A050-09.bed.meta
manually_curated__id	tcga-a2-a0cz-01a-11w-a050-09
manually_curated__md5sum	8146eb2c6cc5a6b2c3c13316cae9e71e
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	95d5c606-367a-46b5-b663-dcea3f42e2a2
manually_curated__tumor_tag	brca
